Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
TXG — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

10.74

Margin Of Safety %

-10

Put/Call OI Ratio

0.41

EPS Next Q Diff

0.12

EPS Last/This Y

0.41

EPS This/Next Y

0.02

Price

59.09

Target Price

68.14

Analyst Recom

2.53

Performance Q

5.37

Upside

-111.4%

Beta

2.03

Ticker: TXG




23 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-10-13TXG71.770.450.2324439
2026-10-14TXG73.140.450.1324597
2026-10-15TXG72.380.420.6524780
2026-10-16TXG69.870.401.0624472
2026-10-19TXG69.840.590.2713995
2026-10-20TXG71.40.590.4214261
2026-10-21TXG75.50.580.7714506
2026-10-22TXG69.730.580.2314601
2026-10-23TXG71.470.550.4115448
2026-10-26TXG72.970.540.2815480
2026-10-27TXG78.010.540.3515514
2026-10-28TXG83.630.540.0515585
2026-10-29TXG81.570.460.3517151
2026-10-30TXG70.110.450.0917438
2026-11-02TXG61.60.450.6218285
2026-11-03TXG65.310.440.1618712
2026-11-04TXG67.470.430.0719177
2026-11-05TXG57.930.420.8819594
2026-11-06TXG59.180.430.4620044
2026-11-09TXG65.130.430.4420007
2026-11-10TXG62.880.430.7520213
2026-11-11TXG62.450.430.4620204
2026-11-12TXG59.080.410.3420046
DateSymbolLatestP/C OIP/C VolTotal OI
23 items Current Page1 of 1




22 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-10-13TXG71.6912.3- 0.04
2026-10-14TXG73.1312.3- 0.04
2026-10-15TXG72.3812.3- 0.04
2026-10-16TXG69.8712.3- 0.04
2026-10-19TXG69.8612.3- 0.04
2026-10-20TXG69.8612.3- 0.04
2026-10-21TXG71.4312.3- 0.04
2026-10-22TXG69.7012.3- 0.04
2026-10-23TXG71.4412.3- 0.04
2026-10-26TXG72.9812.3- 0.04
2026-10-27TXG78.0112.3- 0.04
2026-10-28TXG83.5812.3- 0.04
2026-10-29TXG81.5612.3- 0.04
2026-10-30TXG70.1112.3- 0.04
2026-11-02TXG61.6012.3- 0.04
2026-11-04TXG67.4912.3- 0.04
2026-11-05TXG57.9712.3- 0.04
2026-11-06TXG59.3212.3- 0.04
2026-11-09TXG65.07-100.0- 0.04
2026-11-10TXG62.88-100.0- 0.06
2026-11-11TXG62.02-100.0- 0.06
2026-11-12TXG59.09-100.0- 0.06
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
22 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-10-13TXG-1.967.7313.23
2026-10-14TXG-1.967.7313.23
2026-10-15TXG-1.967.7313.23
2026-10-16TXG-1.967.7313.23
2026-10-19TXG-1.935.7313.23
2026-10-20TXG-1.935.7313.23
2026-10-21TXG-1.935.7313.23
2026-10-22TXG-1.935.7313.23
2026-10-23TXG-1.935.7313.23
2026-10-26TXG-1.935.8313.23
2026-10-27TXG-1.935.8310.96
2026-10-28TXG-1.935.8310.96
2026-10-29TXG-1.935.8310.96
2026-10-30TXG-1.935.8310.96
2026-11-02TXG-1.935.4910.96
2026-11-03TXG-1.935.4910.96
2026-11-05TXG-1.935.4910.96
2026-11-06TXG-1.935.4910.96
2026-11-09TXG-1.935.0910.96
2026-11-10TXG-1.935.0910.96
2026-11-11TXG-1.935.0910.74
2026-11-12TXG-1.935.0910.74
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS​

-0.15

Avg. EPS Est. Current Quarter

-0.04

Avg. EPS Est. Next Quarter

-0.03

Insider Transactions

-1.93

Institutional Transactions

5.09

Beta

2.03

Average Sales Estimate Current Quarter

178

Average Sales Estimate Next Quarter

165

Fair Value

53.44

Quality Score

44

Growth Score

38

Sentiment Score

52

Actual DrawDown %

65

Max Drawdown 5-Year %

-95.7

Target Price

68.14

P/E

Forward P/E

PEG

P/S

12.57

P/B

9.27

P/Free Cash Flow

82.9

EPS

-0.52

Average EPS Est. Cur. Y​

0.06

EPS Next Y. (Est.)

0.09

Target Price Estimates Raised

2

Target Price Estimates Lowered

1

Profit Margin

-10.84

Relative Volume

0.81

Return on Equity vs Sector %

-34.4

Return on Equity vs Industry %

-18.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.03

EBIT Estimation

◆ TXG Healthcare
$59.10
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
16/20
Pullback
17/25
Volume
4/15
Valuation
10/20
TP/AR
5/10
Options
6/10
RSI
40
Range 1M
17.3%
🚀
Momentum Growth
Ride accelerating trends
N/A
47 /100
WEAK
Momentum
13/25
Growth
9/30
Estimates
9/20
Inst/Vol
7/15
Options
9/10
EPS Yr
-79.2%
EPS NY
-7.2%
52W%
50.1%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🔴 SELL -48.8% upside
Quality
6/30
Valuation
3/30
Growth
10/25
Stability
9/10
LT Trend
1/5
Upside
-48.8%
Quality
44
MoS
-10%
TXG — P/E HistoricalHealth Information Services
10x Genomics, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 1178
10x Genomics, Inc. develops and sells instruments, consumables, and software for analyzing biological systems in the United States, rest of the Americas, Europe, the Middle East, Africa, China, and the rest of the Asia Pacific. The company offers Chromium platform, a single cell portfolio that enables analysis of individual biological components, as well as includes microfluidic chips and related consumables, Chromium X Series, and Chromium instruments; and QuantumScale single cell RNA and single cell methylation kits. It also provides Visium platform, a spatial analysis platform that uses high density DNA arrays to encode the physical location of biological analytes within a sample. This platform includes HD WT panel gene expression, and HD 3' gene expression assays, as well as the Visium CytAssist, an instrument designed to simplify and optimize the Visium solution workflow by facilitating the transfer of transcriptomic analytes from standard glass slides to Visium slides. In addition, the company offers Xenium Analyzer instrument enables researchers to detect and preserve the cellular location of hundreds of RNA targets directly in a fresh frozen or FFPE tissue section without the need for conventional sequencing; and slides and reagents. Further, it provides various software products comprising Cell Ranger, a scRNA-seq processing pipeline in scientific literature; Loupe Browser, which enables intuitive single-cell, spatial, and multiomic data visualization; and Xenium Explorer that enables intuitive in situ data visualization, which allows researchers to explore subcellular gene expression, spatial organization, and tissue-scale patterns. The company serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
TXG

Latest News

—
Caricamento notizie per TXG…
stock quote shares TXG – 10x Genomics, Inc. Stock Price stock today
news today TXG – 10x Genomics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch TXG – 10x Genomics, Inc. yahoo finance google finance
stock history TXG – 10x Genomics, Inc. invest stock market
stock prices TXG premarket after hours
ticker TXG fair value insiders trading